OABINasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31Also trades as OABIW

OmniAb, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026

$4.69+0.10 (+2.18%)

Close on Oct 19, 2026

Market cap: $604.05M
P/E (TTM): –
Dividend yield: –

OmniAb, Inc. income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2007 2007-12-31
Revenue	19	26	34	59	35	–
Research & Development	48	55	57	48	39	–
General & Administrative	29	31	33	25	17	–
Operating Expenses	88	101	104	86	70	–
Operating Income	-69	-75	-69	-27	-36	–
Interest Expense	–	–	–	0	0.01	–
Interest & Investment Income	2.66	3.11	5.06	0.59	0	–
Other Non-Operating Income	2.68	3.09	5.06	0.59	1.26	–
Merger & Restructuring Charges	1.90	0	–	–	–	–
Asset Impairment Charges	3.30	0	–	–	–	–
Pretax Income	-66	-71	-64	-26	-34	–
Income Tax Expense	-1.52	-9.38	-14	-3.73	-7.31	–
Net Income	-65	-62	-51	-22	-27	–
EPS (Basic)(per share)	-0.57	-0.61	-0.51	-0.26	-0.33	–
EPS (Diluted)(per share)	-0.57	-0.61	-0.51	-0.26	-0.33	–
Shares Outstanding (Basic, Weighted)(shares)	114	102	100	85	83	–
Shares Outstanding (Diluted, Weighted)(shares)	114	102	100	85	83	–
Dividend per Share(per share)	–	–	–	–	–	2.50
EBITDA	-47	-51	-50	-8.40	-19	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: –
Operating margin: -125.8%
Net margin: -115.1%
Return on equity, FY2025: -23.4%

Financial strength

Current ratio: 4.80
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 176.9%

Valuation

P/E ratio: –
Price to sales: 15.71
Price to book: 2.32
Dividend yield: –